( Log in to your Wikimedia account to use OAuth instead of Quickstatements for updates.)
Author name:
Limit:
Additional SPARQL filters separated by semicolons (eg. for papers on Zika virus, enter wdt:P921 wd:Q202864):
Filter potential authors as well?

Potential publications

50 publications found

Warning: limit reached; process these papers and then reload to see if there are more for this author name string
Click here to create clusters based on exact author strings rather than rougher matches.

Group #1

TitleAuthors (identified)Published InIdentifier(s)TopicPublished DateMatch?
Expression and functional characterization of Smyd1a in myofibril organization of skeletal muscles[1]Jie Gao, [2]Junling Li, [3]Bao-Jun Li, [4]Ezra Yagil, [5]Jianshe Zhang, [6]Shao Jun Du [Full author list]PLOS One [missing]DOI: 10.1371/JOURNAL.PONE.0086808 [ORCID]
PubMed: 24466251 [ORCID]
2014-01-23
Functional analysis of slow myosin heavy chain 1 and myomesin-3 in sarcomere organization in zebrafish embryonic slow muscles[1]Jin Xu, [2]Jie Gao, [3]Junling Li, [4]Liangyi Xue, [5]Karl J. Clark, [6]Stephen C Ekker, [7]Shao Jun Du [Full author list]Journal of Genetics and Genomics [missing]DOI: 10.1016/J.JGG.2012.01.005 [ORCID]
PubMed: 22361506 [ORCID]
2012-01-21

Group #2

TitleAuthors (identified)Published InIdentifier(s)TopicPublished DateMatch?
Chinese Guidelines on the Diagnosis and Treatment of Melanoma (2015 Edition)[1]Jun Guo, [2]Shukui Qin, [3]Jun Liang, [4]Tongyu Lin, [5]Lu Si, [6]Xiaohong Chen, [7]Zhihong Chi, [8]Chuanliang Cui, [9]Nan Du, [10]Yun Fan, [11]Kangsheng Gu, [12]Fang Li, [13]Junling Li, [14]Yongheng Li, [15]Houjie Liang, ... [Full author list]Annals of Translational Medicine [missing]DOI: 10.3978/J.ISSN.2305-5839.2015.12.23 [ORCID]
PubMed: 26734632 [ORCID]
2015-12-01
Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplification[1]Jun Guo, [2]Lu Si, [3]Yan Kong, [4]Keith Flaherty, [5]Xiaowei Xu, [6]Yanyan Zhu, [7]Christopher L Corless, [8]Li Li, [9]Haifu Li, [10]Xinan Sheng, ..., [17]Nan Du, [18]Xiaoshi Zhang, [19]Junling Li, [20]Baocheng Wang, [21]Shukui Qin [Full author list]Journal of Clinical Oncology [missing]DOI: 10.1200/JCO.2010.33.9275 [ORCID]
PubMed: 21690468 [ORCID]
imatinib [missing]; metastatic melanoma [missing]; phase II clinical trial [missing]2011-07-20

Group #3

TitleAuthors (identified)Published InIdentifier(s)TopicPublished DateMatch?
Validation of 2-18F-fluorodeoxysorbitol (18F-FDS) as a potential radiopharmaceutical for imaging bacterial infection in the lung[1]Junling Li, [2]Huaiyu Zheng, [3]Ramy A Fodah, [4]Jonathan Warawa, [5]Chin K Ng [Full author list]The Journal of Nuclear Medicine [missing]DOI: 10.2967/JNUMED.117.195420 [ORCID]
PubMed: 28848037 [ORCID]
2017-08-28
In Vitro PET Imaging of a Miniature Ventricular Assist Device[1]Michael S Gossman, [2]Joel D Graham, [3]Stephen Depot, [4]Huaiyu Zheng, [5]Junling Li, [6]Chin K Ng, [7]Daniel Tamez [Full author list]Journal of Nuclear Medicine Technology [missing]DOI: 10.2967/JNMT.116.175885 [ORCID]
PubMed: 27363444 [ORCID]
2016-06-30
Characterization of (18)F-dipicolylamine (DPA) derivatives in cells infected with influenza virus.[1]Junling Li, [2]Rachael L Gerlach, [3]Colleen B. Jonsson, [4]Brian D Gray, [5]Koon Y Pak, [6]Chin K Ng [Full author list]Nuclear Medicine and Biology [missing]DOI: 10.1016/J.NUCMEDBIO.2014.11.012 [ORCID]
PubMed: 25537726 [ORCID]
2014-12-05
Aptamer imaging with Cu-64 labeled AS1411: preliminary assessment in lung cancer[1]Junling Li, [2]Huaiyu Zheng, [3]Paula J Bates, [4]Tariq Malik, [5]Xiao-Feng Li, [6]John O Trent, [7]Chin K Ng [Full author list]Nuclear Medicine and Biology [missing]DOI: 10.1016/J.NUCMEDBIO.2013.10.008 [ORCID]
PubMed: 24373858 [ORCID]
lung cancer [missing]2013-10-29

Group #4

TitleAuthors (identified)Published InIdentifier(s)TopicPublished DateMatch?
Preclinical characterization of ABT-348, a kinase inhibitor targeting the aurora, vascular endothelial growth factor receptor/platelet-derived growth factor receptor, and Src kinase families[1]Keith B Glaser, [2]Junling Li, [3]Patrick A Marcotte, [4]Terrance J Magoc, [5]Jun Guo, [6]David R Reuter, [7]Paul Tapang, [8]Ru-Qi Wei, [9]Lori J Pease, [10]Mai H Bui, ... [Full author list]Journal of Pharmacology and Experimental Therapeutics [missing]DOI: 10.1124/JPET.112.197087 [ORCID]
PubMed: 22935731 [ORCID]
endothelium [missing]2012-08-30
Bcl-XL represents a druggable molecular vulnerability during aurora B inhibitor-mediated polyploidization[1]O Jameel Shah, [2]Xiaoyu Lin, [3]Leiming Li, [4]Xiaoli Huang, [5]Junling Li, [6]Mark G Anderson, [7]Hua Tang, [8]Luis E Rodriguez, [9]Scott E Warder, [10]Shaun McLoughlin, [11]Jun Chen, [12]Joann Palma, [13]Keith B Glaser, [14]Cherrie K Donawho, [15]Stephen W. Fesik, [16]Yu Shen [Full author list]Proceedings of the National Academy of Sciences of the United States of America [missing]DOI: 10.1073/PNAS.0913615107 [ORCID]
PubMed: 20616035 [ORCID]
whole genome duplication [missing]2010-06-28
3-amino-benzo[d]isoxazoles as novel multitargeted inhibitors of receptor tyrosine kinases[1]Zhiqin Ji, [2]Asma A Ahmed, [3]Daniel H Albert, [4]Jennifer J Bouska, [5]Peter F Bousquet, [6]George A Cunha, [7]Gilbert Diaz, [8]Keith B Glaser, [9]Jun Guo, [10]Christopher M Harris, [11]Junling Li, [12]Patrick A Marcotte, [13]Maria D Moskey, [14]Tetsuro Oie, [15]Lori Pease, [16]Nirupama B Soni, [17]Kent D Stewart, [18]Steven K Davidsen, [19]Michael R Michaelides [Full author list]Journal of Medicinal Chemistry [missing]DOI: 10.1021/JM701096V [ORCID]
PubMed: 18260617 [ORCID]
2008-02-09
ABT-869, a multitargeted receptor tyrosine kinase inhibitor: inhibition of FLT3 phosphorylation and signaling in acute myeloid leukemia[1]Deepa B Shankar, [2]Junling Li, [3]Paul Tapang, [4]J Owen McCall, [5]Lori J Pease, [6]Yujia Dai, [7]Ru-Qi Wei, [8]Daniel H Albert, [9]Jennifer J Bouska, [10]Donald J Osterling, ... [Full author list]Blood [missing]DOI: 10.1182/BLOOD-2006-06-029579 [ORCID]
PubMed: 17209055 [ORCID]
leukemia [missing]; phosphorylation [missing]2007-01-05
Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitor[1]Daniel H Albert, [2]Paul Tapang, [3]Terrance J Magoc, [4]Lori J Pease, [5]David R Reuter, [6]Ru-Qi Wei, [7]Junling Li, [8]Jun Guo, [9]Peter F Bousquet, [10]Nayereh S Ghoreishi-Haack, ... [Full author list]Molecular Cancer Therapeutics [missing]DOI: 10.1158/1535-7163.MCT-05-0410 [ORCID]
PubMed: 16648571 [ORCID]
linifanib [missing]2006-04-01
Thienopyrimidine ureas as novel and potent multitargeted receptor tyrosine kinase inhibitors[1]Yujia Dai, [2]Yan Guo, [3]Robin R Frey, [4]Zhiqin Ji, [5]Michael L Curtin, [6]Asma A Ahmed, [7]Daniel H Albert, [8]Lee Arnold, [9]Shannon S Arries, [10]Teresa Barlozzari, ..., [15]Keith B Glaser, [16]Jun Guo, [17]Junling Li, [18]Patrick A Marcotte, [19]Kennan C Marsh, ... [Full author list]Journal of Medicinal Chemistry [missing]DOI: 10.1021/JM050458H [ORCID]
PubMed: 16162008 [ORCID]
2005-09-01
A novel series of histone deacetylase inhibitors incorporating hetero aromatic ring systems as connection units[1]Yujia Dai, [2]Yan Guo, [3]Michael L. Curtin, [4]Junling Li, [5]Lori J. Pease, [6]Jun Guo, [7]Patrick A. Marcotte, [8]Keith B. Glaser, [9]Steven K. Davidsen, [10]Michael R. Michaelides [Full author list]Bioorganic & Medicinal Chemistry Letters [missing]DOI: 10.1016/J.BMCL.2003.07.012 [ORCID]
PubMed: 14552787 [ORCID]
biochemistry [missing]; organic chemistry [missing]; molecular medicine [missing]; pharmaceutical science [missing]2003-11-03
Alpha-keto amides as inhibitors of histone deacetylase[1]Carol K Wada, [2]Robin R Frey, [3]Zhiqin Ji, [4]Michael L Curtin, [5]Robert B Garland, [6]James H Holms, [7]Junling Li, [8]Lori J Pease, [9]Jun Guo, [10]Keith B Glaser, [11]Patrick A Marcotte, [12]Paul L Richardson, [13]Shannon S Murphy, [14]Jennifer J Bouska, [15]Paul Tapang, [16]Terrance J Magoc, [17]Daniel H Albert, [18]Steven K Davidsen, [19]Michael R Michaelides [Full author list]Bioorganic & Medicinal Chemistry Letters [missing]DOI: 10.1016/S0960-894X(03)00685-1 [ORCID]
PubMed: 12951120 [ORCID]
2003-10-01
Indole amide hydroxamic acids as potent inhibitors of histone deacetylases[1]Yujia Dai, [2]Yan Guo, [3]Jun Guo, [4]Lori J Pease, [5]Junling Li, [6]Patrick A Marcotte, [7]Keith B Glaser, [8]Paul Tapang, [9]Daniel H Albert, [10]Paul L Richardson, [11]Steven K Davidsen, [12]Michael R Michaelides [Full author list]Bioorganic & Medicinal Chemistry Letters [missing]DOI: 10.1016/S0960-894X(03)00301-9 [ORCID]
PubMed: 12749893 [ORCID]
2003-06-01
Transforming growth factor beta mimetics: discovery of 7-[4-(4-cyanophenyl)phenoxy]-heptanohydroxamic acid, a biaryl hydroxamate inhibitor of histone deacetylase[1]Keith B Glaser, [2]Junling Li, [3]Mary E Aakre, [4]Douglas W Morgan, [5]George Sheppard, [6]Kent D Stewart, [7]Jennifer Pollock, [8]Paul Lee, [9]Chad Z O'Connor, [10]Steven N Anderson, [11]Donna J Mussatto, [12]Craig W Wegner, [13]Harold L. Moses [Full author list]Molecular Cancer Therapeutics [missing]PubMed: 12492108 [ORCID]
2002-08-01

Group #5

Matched potential author: Junling Li - author of 9 items
TitleAuthors (identified)Published InIdentifier(s)TopicPublished DateMatch?
Gemcitabine combined with cisplatin as adjuvant chemotherapy for non-small cell lung cancer: A retrospective analysis[1]Di Ma, [2]Jing Wang, [3]Xuezhi Hao, [4]Yan Wang, [5]Xingsheng Hu, [6]Puyuan Xing, [7]Junling Li [Full author list]Thoracic Cancer [missing]DOI: 10.1111/1759-7714.12472 [ORCID]
PubMed: 28745824 [ORCID]
2017-07-26Junling Li (Q91533384; 9 items)
Clinical data from the real world: efficacy of Crizotinib in Chinese patients with advanced ALK-rearranged non-small cell lung cancer and brain metastases[1]Puyuan Xing, [2]Shouzheng Wang, [3]Xuezhi Hao, [4]Tongtong Zhang, [5]Junling Li [Full author list]Oncotarget [missing]DOI: 10.18632/ONCOTARGET.13179 [ORCID]
PubMed: 27835868 [ORCID]
lung cancer [missing]; brain metastasis [missing]; crizotinib [missing]2016-11-07Junling Li (Q91533384; 9 items)
Clinicopathologic Characteristics of the Patients in the Elderly Lung Carcinoma[1]Jie Chen, [2]Xuezhi Hao, [3]Fang Cheng, [4]Tongtong Zhang, [5]Puyuan Xing, [6]Junling Li [Full author list]Chinese Journal of Lung Cancer [missing]DOI: 10.3779/J.ISSN.1009-3419.2016.10.07 [ORCID]
PubMed: 27760597 [ORCID]
2016-10-01Junling Li (Q91533384; 9 items)
Recombinant Human Endostatin in the Treatment of Advanced Lung Squamous Cell Carcinoma[1]Puyuan Xing, [2]Xuezhi Hao, [3]Xingsheng Hu, [4]Yan Wang, [5]Junling Li [Full author list]Chinese Journal of Lung Cancer [missing]DOI: 10.3779/J.ISSN.1009-3419.2016.10.06 [ORCID]
PubMed: 27760596 [ORCID]
2016-10-01Junling Li (Q91533384; 9 items)
Responses to crizotinib in patients with ALK-positive lung adenocarcinoma who tested immunohistochemistry (IHC)-positive and fluorescence in situ hybridization (FISH)-negative[1]Di Ma, [2]Zheng Wang, [3]Lin Yang, [4]Xinlin Mu, [5]Yan Wang, [6]Xinming Zhao, [7]Junling Li, [8]Dongmei Lin [Full author list]Oncotarget [missing]DOI: 10.18632/ONCOTARGET.10560 [ORCID]
PubMed: 27418132 [ORCID]
adenocarcinoma [missing]; immunohistochemistry [missing]; crizotinib [missing]2016-07-13Junling Li (Q91533384; 9 items)
Clinical effect of pemetrexed as the first-line treatment in Chinese patients with advanced anaplastic lymphoma kinase-positive non-small cell lung cancer[1]Di Ma, [2]Xuezhi Hao, [3]Yan Wang, [4]Puyuan Xing, [5]Junling Li [Full author list]Thoracic Cancer [missing]DOI: 10.1111/1759-7714.12353 [ORCID]
PubMed: 27385988 [ORCID]
lung cancer [missing]2016-05-11Junling Li (Q91533384; 9 items)
Efficacy of Cetuximab in Combination with Chemotherapy in Advanced Non-small Cell Lung Cancer[1]Sheng Yang, [2]Yan Wang, [3]Xingsheng Hu, [4]Hongyu Wang, [5]Xuezhi Hao, [6]Jianping Xu, [7]Lin Wang, [8]Bin Wang, [9]Junling Li, [10]Longmei Zhao, [11]Peidi Jiang, [12]Fenglian Qu, [13]Xiangru Zhang, [14]Yuankai Shi [Full author list]Chinese Journal of Lung Cancer [missing]DOI: 10.3779/J.ISSN.1009-3419.2016.05.03 [ORCID]
PubMed: 27215454 [ORCID]
cetuximab [missing]2016-05-01Junling Li (Q91533384; 9 items)
A prognostic model for platinum-doublet as second-line chemotherapy in advanced non-small-cell lung cancer patients[1]Hongnan Mo, [2]Xuezhi Hao, [3]Yutao Liu, [4]Lin Wang, [5]Xingsheng Hu, [6]Jianping Xu, [7]Sheng Yang, [8]Puyuan Xing, [9]Youwu Shi, [10]Bo Jia, [11]Yan Wang, [12]Junling Li, [13]Hongyu Wang, [14]Ziping Wang, [15]Yan Sun, [16]Yuankai Shi [Full author list]Cancer Medicine [missing]DOI: 10.1002/CAM4.689 [ORCID]
PubMed: 26993156 [ORCID]
platinum [missing]2016-03-19Junling Li (Q91533384; 9 items)

Group #6

TitleAuthors (identified)Published InIdentifier(s)TopicPublished DateMatch?
Enhanced Light Scattering of Secondary Organic Aerosols by Multiphase Reactions[1]Kun Li, [2]Junling Li, [3]John Liggio, [4]Weigang Wang, [5]Maofa Ge, [6]Qifan Liu, [7]Yucong Guo, [8]Shengrui Tong, [9]Jiangjun Li, [10]Chao Peng, [11]Bo Jing, [12]Dong Wang, [13]Pingqing Fu [Full author list]Environmental Science & Technology [missing]DOI: 10.1021/ACS.EST.6B03229 [ORCID]
PubMed: 28052190 [ORCID]
aerosol [missing]2017-01-04
Optical properties of secondary organic aerosols derived from long-chain alkanes under various NOx and seed conditions[1]Junling Li, [2]Kun Li, [3]Weigang Wang, [4]Jing Wang, [5]Chao Peng, [6]Maofa Ge [Full author list]Science of the Total Environment [missing]DOI: 10.1016/J.SCITOTENV.2016.11.189 [ORCID]
PubMed: 27916309 [ORCID]
nitrogen oxide [missing]2016-12-01

Group #7

Matched potential author: Junling Li - author of 9 items
TitleAuthors (identified)Published InIdentifier(s)TopicPublished DateMatch?
Observation of hepatotoxicity during long-term gefitinib administration in patients with non-small-cell lung cancer[1]Jingjing Wang, [2]Yanlin Wu, [3]Mei Dong, [4]Xiaohui He, [5]Ziping Wang, [6]Junling Li, [7]Yan Wang [Full author list]Anti-Cancer Drugs [missing]DOI: 10.1097/CAD.0000000000000323 [ORCID]
PubMed: 26633888 [ORCID]
hepatotoxicity [missing]2015-12-02
Phase II trial of paclitaxel-carboplatin with intercalated gefitinib for untreated, epidermal growth factor receptor gene mutation status unknown non-small cell lung cancer[1]Jianliang Yang, [2]Yuankai Shi, [3]Xiangru Zhang, [4]Jianping Xu, [5]Bin Wang, [6]Xuezhi Hao, [7]Junling Li, [8]Wang Yan [Full author list]Thoracic Cancer [missing]DOI: 10.1111/1759-7714.12074 [ORCID]
PubMed: 26766992 [ORCID]
phase II clinical trial [missing]2014-03-03Junling Li (Q91533384; 9 items)
Clinical report of combined chemotherapy with gemcitabine plus cisplatin as first-line treatment to 79 cases of advanced non-small cell lung cancer[1]Lin Lin, [2]Xuezhi Hao, [3]Junling Li, [4]Ziping Wang, [5]Yan Wang, [6]Hongyu Wang, [7]Xingsheng Hu, [8]Xiangru Zhang [Full author list]Chinese Journal of Lung Cancer [missing]DOI: 10.3779/J.ISSN.1009-3419.2007.06.14 [ORCID]
PubMed: 21129311 [ORCID]
2007-12-01Junling Li (Q91533384; 9 items)
Weekly administration of gemcitabine and docetaxel combinations in the treatment of advanced non-small cell lung cancer[1]Junling Li, [2]Yilong Wu, [3]Longyun Li, [4]Lijia Gu, [5]Li Zhang, [6]Jinwan Wang, [7]Xiangru Zhang, [8]Yan Sun [Full author list]Chinese Journal of Lung Cancer [missing]DOI: 10.3779/J.ISSN.1009-3419.2003.05.13 [ORCID]
PubMed: 21306683 [ORCID]
docetaxel [missing]2003-10-01

Group #8

Matched potential author: Junling Li - author of 9 items
TitleAuthors (identified)Published InIdentifier(s)TopicPublished DateMatch?
Is there an optimal time to initiate adjuvant chemotherapy to predict benefit of survival in non-small cell lung cancer?[1]Yutao Liu, [2]Xiaoyu Zhai, [3]Junling Li, [4]Zhiwen Li, [5]Di Ma, [6]Ziping Wang [Full author list]Chinese Journal of Cancer Research [missing]DOI: 10.21147/J.ISSN.1000-9604.2017.03.12 [ORCID]
PubMed: 28729777 [ORCID]
2017-06-01
Impact of platinum/pemetrexed combination versus other platinum-based regimens on adjuvant chemotherapy in resected lung adenocarcinoma[1]Xiaoyu Zhai, [2]Qiwen Zheng, [3]Lu Yang, [4]Yixiang Zhu, [5]Junling Li, [6]Yutao Liu, [7]Ziping Wang [Full author list]Scientific Reports [missing]DOI: 10.1038/S41598-017-01347-6 [ORCID]
PubMed: 28469143 [ORCID]
adenocarcinoma [missing]2017-05-03
Detection of ALK translocation in non-small cell lung carcinoma (NSCLC) and its clinicopathological significance using the Ventana immunohistochemical staining method: a single-center large-scale investigation of 1, 504 Chinese Han patients[1]Lin Yang, [2]Yun Ling, [3]Lei Guo, [4]Di Ma, [5]Xuemin Xue, [6]Bingning Wang, [7]Junling Li, [8]Jianming Ying [Full author list]Chinese Journal of Cancer Research [missing]DOI: 10.21147/J.ISSN.1000-9604.2016.05.04 [ORCID]
PubMed: 27877008 [ORCID]
immunohistochemistry [missing]; lung carcinoma [missing]2016-10-01Junling Li (Q91533384; 9 items)

Group #9

TitleAuthors (identified)Published InIdentifier(s)TopicPublished DateMatch?
Research on the traditional Chinese medicine treating gastrointestinal motility in diabetic rats by improving biomechanical remodeling and neuroendocrine regulation[1]Jiaxing Tian, [2]Min Li, [3]Jingbo Zhao, [4]Junling Li, [5]Guifang Liu, [6]Zhong Zhen, [7]Yang Cao, [8]Hans Gregersen, [9]Xiaolin Tong [Full author list]American Journal of Translational Research [missing]PubMed: 28559973 [ORCID]
biomechanics [missing]; traditional Chinese medicine [missing]2017-05-15
Chinese herbal medicine banxiaxiexin decoction treating diabetic gastroparesis: a systematic review of randomized controlled trials[1]Jiaxing Tian, [2]Min Li, [3]Jiangquan Liao, [4]Junling Li, [5]Xiaolin Tong [Full author list]Evidence-based Complementary and Alternative Medicine [missing]DOI: 10.1155/2013/749495 [ORCID]
PubMed: 23935681 [ORCID]
herbalism [missing]; gastroparesis [missing]; systematic review [missing]2013-07-11

Group #10

TitleAuthors (identified)Published InIdentifier(s)TopicPublished DateMatch?
(18)F-misonidazole PET imaging of hypoxia in micrometastases and macroscopic xenografts of human non-small cell lung cancer: a correlation with autoradiography and histological findings[1]Tao Huang, [2]A Cahid Civelek, [3]Huaiyu Zheng, [4]Chin K Ng, [5]Xiaoxian Duan, [6]Junling Li, [7]Gregory C Postel, [8]Baozhong Shen, [9]Xiao-Feng Li [Full author list]American journal of nuclear medicine and molecular imaging [missing]PubMed: 23526377 [ORCID]
xenograft [missing]2013-03-08
Tumor microenvironment-dependent 18F-FDG, 18F-fluorothymidine, and 18F-misonidazole uptake: a pilot study in mouse models of human non-small cell lung cancer[1]Tao Huang, [2]A Cahid Civelek, [3]Junling Li, [4]Huijie Jiang, [5]Chin K Ng, [6]Gregory C Postel, [7]Baozhong Shen, [8]Xiao-Feng Li [Full author list]The Journal of Nuclear Medicine [missing]DOI: 10.2967/JNUMED.111.098087 [ORCID]
PubMed: 22717978 [ORCID]
lung cancer [missing]2012-06-19

Group #11

TitleAuthors (identified)Published InIdentifier(s)TopicPublished DateMatch?
Consolidation chemotherapy may improve survival for patients with locally advanced non-small-cell lung cancer receiving concurrent chemoradiotherapy--retrospective analysis of 203 cases[1]Lipin Liu, [2]Nan Bi, [3]Zhe Ji, [4]Junling Li, [5]Jingbo Wang, [6]Xiaozhen Wang, [7]Zhouguang Hui, [8]Jima Lv, [9]Jun Liang, [10]Zongmei Zhou, [11]Yan Wang, [12]Weibo Yin, [13]Luhua Wang [Full author list]BMC Cancer [missing]DOI: 10.1186/S12885-015-1710-2 [ORCID]
PubMed: 26474893 [ORCID]
chemotherapy [missing]; chemoradiotherapy [missing]2015-10-16
Radiation recall pneumonitis induced by chemotherapy after thoracic radiotherapy for lung cancer[1]Xiao Ding, [2]Wei Ji, [3]Junling Li, [4]Xiangru Zhang, [5]Luhua Wang [Full author list]Radiation Oncology [missing]DOI: 10.1186/1748-717X-6-24 [ORCID]
PubMed: 21375774 [ORCID]
lung cancer [missing]; Adaptive radiation therapy [missing]; chemotherapy [missing]2011-03-06

Group #12

Matched potential author: Junling Li - author of 9 items
TitleAuthors (identified)Published InIdentifier(s)TopicPublished DateMatch?
Molecular Epidemiology of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell Lung Cancer of Adenocarcinoma Histology - Mainland China Subset Analysis of the PIONEER study[1]Yuankai Shi, [2]Junling Li, [3]Shucai Zhang, [4]Mengzhao Wang, [5]Shujun Yang, [6]Ning Li, [7]Gang Wu, [8]Wei Liu, [9]Guoqing Liao, [10]Kaican Cai, [11]Liang'an Chen, [12]Meizhen Zheng, [13]Ping Yu, [14]Xiuwen Wang, [15]Yunpeng Liu, [16]Qisen Guo, [17]Ligong Nie, [18]Jiwei Liu, [19]Xiaohong Han [Full author list]PLOS One [missing]DOI: 10.1371/JOURNAL.PONE.0143515 [ORCID]
PubMed: 26599344 [ORCID]
People's Republic of China [missing]; lung cancer [missing]; epidemiology [missing]; adenocarcinoma [missing]2015-11-23
Recurrent response to advanced lung adenocarcinoma with erlotinib developing leptomeningeal metastases during gefitinib therapy and two case reports.[1]Puyuan Xing, [2]Junling Li, [3]Yuankai Shi, [4]Xiangru Zhang [Full author list]Thoracic Cancer [missing]DOI: 10.1111/1759-7714.12049 [ORCID]
PubMed: 26766970 [ORCID]
adenocarcinoma [missing]2014-01-02Junling Li (Q91533384; 9 items)

Misc

TitleAuthors (identified)Published InIdentifier(s)TopicPublished DateMatch?
Effect of socioeconomic status on stage at diagnosis of lung cancer in a hospital-based multicenter retrospective clinical epidemiological study in China, 2005-2014[1]Yuanqiu Li, [2]Jufang Shi, [3]Shicheng Yu, [4]Le Wang, [5]Jianjun Liu, [6]Jiansong Ren, [7]Shugeng Gao, [8]Zhouguang Hui, [9]Junling Li, [10]Ning Wu, [11]Boyan Yang, ... [Full author list]Cancer Medicine [missing]DOI: 10.1002/CAM4.1170 [ORCID]
PubMed: 28941012 [ORCID]
socioeconomics [missing]; multicenter clinical trial [missing]2017-09-21
Effects of Bu Shen Yi sui capsule on NogoA/NgR and its signaling pathways RhoA/ROCK in mice with experimental autoimmune encephalomyelitis[1]Ling Fang, [2]Yongqiang Wang, [3]Qi Zheng, [4]Tao Yang, [5]Peiyuan Zhao, [6]Hui Zhao, [7]Qiuxia Zhang, [8]Yuanyuan Zhao, [9]Fang Qi, [10]Kangning Li, [11]Zhenzhen Chen, [12]Junling Li, [13]Nan Zhang, [14]Yongping Fan, [15]Lei Wang [Full author list]BMC Complementary and Alternative Medicine [missing]DOI: 10.1186/S12906-017-1847-4 [ORCID]
PubMed: 28668079 [ORCID]
experimental autoimmune encephalomyelitis [missing]2017-07-01
Xylan synthesized by Irregular Xylem 14 (IRX14) maintains the structure of seed coat mucilage in Arabidopsis[1]Ruibo Hu, [2]Junling Li, [3]Xiaoyu Wang, [4]Xun Zhao, [5]Xuanwen Yang, [6]Qi Tang, [7]Guo He, [8]Gongke Zhou, [9]Yingzhen Kong [Full author list]Journal of Experimental Botany [missing]DOI: 10.1093/JXB/ERV510 [ORCID]
PubMed: 26834178 [ORCID]
xylem [missing]; mucilage [missing]2016-02-01
Quantum dot cluster (QDC)-loaded phospholipid micelles as a FRET probe for phospholipase A2 detection[1]Junling Li, [2]Yonghua Zhang, [3]Junjie Ai, [4]Qiang Gao, [5]Honglan Qi, [6]Chengxiao Zhang, [7]Zhiliang Cheng [Full author list]RSC Advances [missing]DOI: 10.1039/C5RA25292J [ORCID]
PubMed: 26998254 [ORCID]
micelles [missing]; quantum dot [missing]2016-01-01
Safety Profile of TiO₂-Based Photocatalytic Nanofabrics for Indoor Formaldehyde Degradation[1]Guixin Cui, [2]Yan Xin, [3]Xin Jiang, [4]Mengqi Dong, [5]Junling Li, [6]Peng Wang, [7]Shumei Zhai, [8]Yongchun Dong, [9]Jianbo Jia, [10]Bing Yan [Full author list]International Journal of Molecular Sciences [missing]DOI: 10.3390/IJMS161126055 [ORCID]
PubMed: 26610470 [ORCID]
photocatalysis [missing]2015-11-19
Histological subtypes of lung cancer in Chinese women from 2000 to 2012.[1]Xiao Nong Zou, [2]Dongmei Lin, [3]Ann Chao, [4]Xia Wan, [5]Qinfu Feng, [6]Junling Li, [7]Jie Yang, [8]Gong Huan Yang, [9]Ning Lv [Full author list]Thoracic Cancer [missing]DOI: 10.1111/1759-7714.12121 [ORCID]
PubMed: 26767037 [ORCID]
2014-08-25
Loss of Smyhc1 or Hsp90alpha1 function results in different effects on myofibril organization in skeletal muscles of zebrafish embryos[1]Marta Codina, [2]Junling Li, [3]Joaquim Gutiérrez, [4]Joseph P Y Kao, [5]Shao Jun Du [Full author list]PLOS One [missing]DOI: 10.1371/JOURNAL.PONE.0008416 [ORCID]
PubMed: 20049323 [ORCID]
Danio rerio [missing]; Heat shock protein 90, alpha (cytosolic), class A member 1, tandem duplicate 1 [missing]2010-01-01

Potential author items

NameDescriptionAuthored itemsIdentifiersEmployer(s)
Junling Liresearcher (ORCID 0000-0002-7361-325X)9ORCID: 0000-0002-7361-325X
Other Q number of this author

New Author Item

(if the author you are looking for is not listed above and otherwise not yet in Wikidata)
Author name:
Check ORCID for Junling Li | Author has ORCID ID:
Check VIAF for Junling Li | Author has VIAF ID:
Check ResearchGate for Junling Li | Author has ResearchGate Profile ID:
After creating the new author item, enter the Wikidata ID in the "Other Q number of this author" field above to link to their works.

Author items in these papers

Common author name strings in these papers

Publishing venues for these papers

Topics for these papers

Feedback
Source and documentation (at github)
Wikidata page